44个国家COVID-19疫苗政策制定——2021年12月国家免疫技术咨询小组(NITAG)调查主要发现
2021年12月对44个国家NITAG的在线调查评估了WHO SAGE新冠疫苗指南文件的有用性及NITAG面临的需求与挑战。结果显示SAGE建议易于获取、理解和改编,在数据和时限受限情况下仍全面及时;高收入国家偏好通过全球NITAG网络(GNN)解决问题,低收入国家则倾向WHO国家或区域办事处。NITAG重视彼此互动,需促进区域内的交流机会。
要点
- SAGE新冠疫苗建议被NITAG认为易于获取、理解和改编,且全面及时。
- 高收入国家偏好通过GNN解决疑问,低收入国家更倾向WHO国家或区域办事处。
- 部分NITAG需处理SAGE通常未考虑的问题,如供应链物流和疫苗需求。
核心结论
- SAGE新冠疫苗建议易于获取、理解和改编,在数据和时限受限情况下仍全面及时。
- NITAG重视与其他NITAG的互动,需要促进并增加区域内机会。
- 部分NITAG在疫情期间需处理SAGE通常未考虑的问题,如供应链物流和疫苗需求。
- 从COVID-19经验中学习可通过制定更具体程序和考虑更多类型数据(包括实施效果和接种数据)来加强NITAG和大流行恢复工作。
- 有机会增加WHO国家办事处人员的参与以支持NITAG,同时确保国家信息和证据需求在SAGE审议中得到充分反映。
研究设计与样本
- 2021年12月开展的在线调查,覆盖44个国家的NITAG,旨在评估SAGE指南文件对COVID-19疫苗政策的有用性并考察NITAG持续的需求和挑战。
主要发现
- SAGE关于COVID-19疫苗的建议易于获取、理解和改编,且在SAGE面临的数据和时间受限情况下被认定为全面及时。
- 全球NITAG网络(GNN)似乎是高收入国家解决问题最常用的途径,而低收入国家更倾向于WHO国家或区域办事处。
- NITAG高度重视与其他NITAG的互动,这需要 facilitation 并可从增加的机会中受益,尤其是在区域内。
- 部分NITAG在疫情期间不得不处理SAGE通常未考虑的问题,如供应链物流和疫苗需求。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
National Immunization Technical Advisory Committees (NITAGs) are tasked with the responsibility of guiding ministries of health and national immunization programmes in their policy development processes. Many NITAGs rely on evidence reviewed by the World Health Organization's (WHO) Strategic Group of Experts(SAGE) on immunization and aim to adapt WHO's recommendations to their respective contexts. This relationship took on exceptional importance since the onset of the COVID-19 pandemic, during which NITAGs have expressed a notable struggle to craft appropriate policies on population prioritization and vaccine utilization in the face of supply constraints and complex programmatic and delivery logistics. This online survey was conducted to assess the usefulness of the SAGE guidance documents for COVID-19 vaccine policies and to examine the persisting needs and challenges facing NITAGs. Results confirmed that SAGE recommendations concerning COVID-19 vaccines are easy to access, understand, and adapt. They have been found to be comprehensive and timely under the data and time constrained circumstances confronting SAGE. The Global NITAG Network (GNN) appears to be the most popular vehicle for addressing questions among high income countries, in contrast to lower income countries who favour WHO Country or Regional Offices. NITAGs place much value on interaction with other NITAGs, which requires facilitation and could benefit from increased opportunities, especially within regions. It is further noted that some NITAGs have had to tackle issues during the pandemic not typically considered by SAGE, such as supply chain logistics and vaccine demand. Learning from the COVID-19 experience offers opportunities to strengthen NITAGs and the pandemic recovery effort through the development of more concrete procedures and consideration of more varied types of data, including implementation effectiveness and uptake data. There is also an opportunity for an increasing involvement of Country Office WHO personnel to support NITAGs, while ensuring information and evidence needs of countries are adequately reflected in SAGE deliberations.
引用
- Kahn AL, Steffen CA, Henaff L, et al. COVID-19 vaccine policy development in a sample of 44 countries - Key findings from a December 2021 survey of National Immunization Technical Advisory Groups (NITAGs). Vaccine. 2022. PMID: 36494252. doi:10.1016/j.vaccine.2022.11.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。